Catalent Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
This is Juan Avendano, the CRO and CDMO analyst at Bank of America. I'd like to thank you for participating in the 2020 BofA Healthcare Conference, which is virtual this year.
I am pleased to be joined by Wetteny Joseph, CEO -- CFO of Catalent, a leading U.S. CDMO as well as Paul Surdez from Investor Relations. Thank you very much for your participation, and hope you're doing well.
I guess I'd like to kick it off, Wetteny, if you could start out with some introductory comments on Catalent, and how the business has been impacted and responding to the COVID-19 pandemic, that be great.
Sure, Juan, that was almost a promotion there that you almost gave me, but I appreciate the intro.
Before I get going here, I just may be using some forward-looking statements in the commentary today, Juan and everybody. So I would just refer you to our SEC filings, so that you better understand the risk and uncertainties that may bear on the operating results and financial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |